Hepion Pharmaceuticals, Inc. (HEPA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-04-27

Hepion Pharmaceuticals, Inc. (HEPA) has filed 4 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-04-27. 2 Form 8-K material event filings were reported by HEPA in the last 90 days. InsiderAlpha tracks every HEPA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Hepion Pharmaceuticals, Inc. (HEPA)

SEC CIK	0001583771

90-Day SEC Filing Activity

Form 4 filings (90d)	4
Form 8-K filings (90d)	2
Latest Form 4 filing	2026-04-27

Recent HEPA Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-04-21	LoPriore Vincent S	Executive Chairman	P — Open-market purchase	5.00M	$0.04	$200K	SEC
2026-04-21	LoPriore Vincent S	Executive Chairman	P — Open-market purchase	1.25M	$0.04	$50K	SEC
2026-04-21	Appajosyula Sireesh	Director	P — Open-market purchase	1.25M	$0.04	$50K	SEC
2026-04-21	Stetz Gary S.	Interim CEO	P — Open-market purchase	1.25M	$0.04	$50K	SEC
2026-04-21	Purcell Michael J.	Director	P — Open-market purchase	1.25M	$0.04	$50K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Hepion Pharmaceuticals, Inc. (HEPA). Updated in real time as new filings are submitted to the SEC.

Most-Active HEPA Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
LoPriore Vincent S	2	$250K
Purcell Michael J.	1	$50K
Appajosyula Sireesh	1	$50K
Stetz Gary S.	1	$50K

Recent HEPA Form 8-K Material Events

2026-07-02 — Item 5.02 [SEC]
2026-06-17 — Item 5.07 [SEC]

Recent Insider Filings

2026-04-27 — Purcell Michael J. (Director)
2026-04-27 — LoPriore Vincent S (Executive Chairman)
2026-04-27 — Appajosyula Sireesh (Director)
2026-04-27 — Stetz Gary S. (Interim CEO)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in HEPA insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

HEPA Insider Trading — FAQ

What is the latest insider trade for HEPA?: Hepion Pharmaceuticals, Inc. (HEPA) had 4 insider filings in the last 90 days, with the most recent on 2026-04-27. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying HEPA stock?: 0 insider purchases of HEPA were filed in the last 90 days.
How many insiders are selling HEPA stock?: 0 insider sales of HEPA were filed in the last 90 days.
Where can I see HEPA SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every HEPA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live HEPA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.